Dr. Rosen explains the available treatment options for patients diagnosed with diffuse large B-cell lymphomas.
Treatments for diffuse large B-cell lymphoma in general involve chemotherapy, usually multiple agents. We call this combination chemotherapy and antibody therapy, and as a result of the combination of chemotherapy and antibody therapy, we can cure approximately half of the individuals diagnosed with diffuse large B-cell lymphoma.
About Dr. Steven Rosen, M.D., F.A.C.P:
Steven Rosen, M.D., F.A.C.P., is Genevieve Teuton Professor of Medicine, at the Feinberg School of Medicine, Northwestern University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Director of Cancer Programs at Northwestern Memorial Hospital. Following his graduation with distinction from Northwestern University Medical School's Six-Year Honors Program in 1976, Dr. Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr. Rosen's laboratory research focuses on experimental therapeutics and hematologic malignancies.